Leidos Holdings Net Total Equity Issued/Repurchased 2010-2024 | LDOS
Leidos Holdings annual/quarterly net total equity issued/repurchased history and growth rate from 2010 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
- Leidos Holdings net total equity issued/repurchased for the quarter ending December 31, 2024 was $-0.851B, a 334.18% increase year-over-year.
- Leidos Holdings net total equity issued/repurchased for the twelve months ending December 31, 2024 was $-1.764B, a 600% increase year-over-year.
- Leidos Holdings annual net total equity issued/repurchased for 2024 was $-0.851B, a 334.18% increase from 2023.
- Leidos Holdings annual net total equity issued/repurchased for 2023 was $-0.196B, a 60.32% decline from 2022.
- Leidos Holdings annual net total equity issued/repurchased for 2022 was $-0.494B, a 118.58% increase from 2021.
Leidos Holdings Annual Net Total Equity Issued/Repurchased (Millions of US $) |
2024 |
$-851 |
2023 |
$-196 |
2022 |
$-494 |
2021 |
$-226 |
2020 |
$-70 |
2019 |
$-431 |
2018 |
$-424 |
2017 |
$-18 |
2016 |
$1 |
2015 |
$-112 |
2015 |
$-208 |
2014 |
$-306 |
2013 |
$-3 |
2012 |
$-444 |
2011 |
$-563 |
2010 |
$-416 |
2009 |
$-369 |
Sector |
Industry |
Market Cap |
Revenue |
Aerospace |
Aerospace and Defense General |
$16.829B |
$16.662B |
Leidos Holdings, Inc. is a global science and technology leader that serves the defense, intelligence, civil and health markets. Its core capabilities include providing solutions in the fields of cybersecurity; data analytics; enterprise IT modernization; operations and logistics; sensors, collection and phenomenology; software development; and systems engineering. Outside the United State, the company's international customers include foreign governments and their agencies, primarily located in the United Kingdom, the Middle East and Australia. Leidos Holdings currently operates through three business segments namely - Defense Solutions, Civil and Health.
|